Viscom AG (ETR:V6C) | WebDisclosure

PRESS RELEASE

published on 11/14/2024 at 07:55, 1 year 4 months ago

Viscom SE: Persistent market weakness characterises business performance in the first nine months of 2024
Viscom SE reports a decline in revenue and EBIT in the first nine months of 2024 amidst challenging market conditions. Strategic focus on cost-cutting and innovation to navigate market uncertainties

Innovation Market Challenges Revenue Decline Cost-cutting Viscom SE
BRIEF

published on 08/08/2024 at 07:05, 1 year 7 months ago

Viscom SE : la faible demande affecte les performances du premier semestre 2024 ; Prévisions annuelles ajustées

Prévisions De Revenus Performances 2024 Mesures De Réduction Des Coûts Viscom SE Faible Demande
BRIEF

published on 08/08/2024 at 07:05, 1 year 7 months ago

Viscom SE: Weak Demand Affects First Half of 2024 Performance; Annual Forecast Adjusted

Revenue Forecast Cost-cutting Measures Weak Demand 2024 Performance Viscom SE
PRESS RELEASE

published on 08/08/2024 at 07:00, 1 year 7 months ago

Viscom SE: Weak demand characterises business performance in the first half of 2024; Adjustment of the annual forecast despite continued limited predictability
Viscom SE experiences weak demand leading to an adjustment of annual forecast; Incoming orders and revenue decline in the first half of 2024

Forecast Adjustment Business Performance Weak Demand Incoming Orders Viscom SE
BRIEF

published on 08/06/2024 at 18:47, 1 year 7 months ago

Viscom SE Adjusts Annual Forecast for 2024 Financial Year

Financial Year EBIT Margin 2024 Forecast Earnings Impact Viscom SE
BRIEF

published on 08/06/2024 at 18:47, 1 year 7 months ago

Viscom SE ajuste ses prévisions annuelles pour l'exercice 2024

Prévisions 2024 Marge EBIT Année Financière Viscom SE Impact Sur Les Bénéfices
PRESS RELEASE

published on 08/06/2024 at 18:42, 1 year 7 months ago

EQS-Adhoc: Viscom SE: Adjustment of the annual forecast for the 2024 financial year
Viscom SE adjusts annual forecast for 2024 financial year, expecting EBIT margin before non-recurring effects between -3% and -9% due to capacity underutilization and delays in projects

EBIT Margin 2024 Financial Year Annual Forecast Viscom SE Capacity Underutilization
BRIEF

published on 06/06/2024 at 13:41, 1 year 9 months ago

Viscom finalise le changement de forme juridique en société européenne (SE)

Société Européenne Industrie Électronique SE Viscom Forme Juridique
BRIEF

published on 06/06/2024 at 13:41, 1 year 9 months ago

Viscom Completes Change of Legal Form to a European Company (SE)

Electronics Industry Legal Form SE Viscom European Company
PRESS RELEASE

published on 06/06/2024 at 13:36, 1 year 9 months ago

Viscom completes change of legal form to a European Company (Societas Europaea - SE)
Viscom completes change of legal form to a European Company (SE), enhancing its European and international presence. SE works council to promote cross-border cooperation among employees

Legal Form SE International Orientation Viscom European Company

Published on 03/26/2026 at 23:00, 2 hours 47 minutes ago

FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 3 hours 42 minutes ago

BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 3 hours 47 minutes ago

Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 3 hours 47 minutes ago

Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 4 hours 47 minutes ago

Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity

View all ACCESSWIRE

Published on 03/26/2026 at 20:48, 4 hours 58 minutes ago

Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 6 hours 26 minutes ago

Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:13, 6 hours 33 minutes ago

Director Declaration
Published on 03/26/2026 at 19:09, 6 hours 37 minutes ago

2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Published on 03/26/2026 at 19:09, 6 hours 37 minutes ago

2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)

View all EQS

Published on 03/26/2026 at 18:17, 7 hours 30 minutes ago

Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 7 hours 30 minutes ago

Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 7 hours 47 minutes ago

Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 7 hours 47 minutes ago

Calendrier financier 2026
Published on 03/26/2026 at 18:00, 7 hours 47 minutes ago

LABORATOIRES EUROMEDIS - Fin du contrat de liquidité

View all LES ECHOS COMFI WIRE

News